Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events.

Sasaoka S, Matsui T, Hane Y, Abe J, Ueda N, Motooka Y, Hatahira H, Fukuda A, Naganuma M, Hasegawa S, Kinosada Y, Nakamura M.

PLoS One. 2016 Oct 10;11(10):e0164309. doi: 10.1371/journal.pone.0164309. eCollection 2016.

2.

QT interval variations and mortality risk: is there any relationship?

RezuĊŸ C, Moga VD, Ouatu A, Floria M.

Anatol J Cardiol. 2015 Mar;15(3):255-8. doi: 10.5152/akd.2015.5875.

3.

QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey.

Zhang Y, Post WS, Dalal D, Blasco-Colmenares E, Tomaselli GF, Guallar E.

Arch Intern Med. 2011 Oct 24;171(19):1727-33. doi: 10.1001/archinternmed.2011.433.

4.

Electrocardiographic QT interval and mortality: a meta-analysis.

Zhang Y, Post WS, Blasco-Colmenares E, Dalal D, Tomaselli GF, Guallar E.

Epidemiology. 2011 Sep;22(5):660-70. doi: 10.1097/EDE.0b013e318225768b.

5.

Short QT syndrome: from bench to bedside.

Patel C, Yan GX, Antzelevitch C.

Circ Arrhythm Electrophysiol. 2010 Aug;3(4):401-8. doi: 10.1161/CIRCEP.109.921056. Review. No abstract available.

6.

Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Shah RR.

Br J Pharmacol. 2010 Jan;159(1):58-69. doi: 10.1111/j.1476-5381.2009.00191.x. Epub 2009 Jun 25. Review.

Supplemental Content

Support Center